• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1070250-48
Device Problems Deflation Problem (1149); Improper or Incorrect Procedure or Method (2017); Difficult to Advance (2920)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/29/2019
Event Type  malfunction  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.(b)(4).The stent remains in the patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was to treat a moderately tortuous and heavily calcified proximal right coronary artery that was 80% stenosed.Pre-dilatation was performed and a 2.5 x 48 mm xience xpedition stent was advanced and initially met resistance with the anatomy.The stent was deployed once at 14 atmospheres; however, it was initially difficult to deflate the stent delivery balloon.The balloon was then ultimately deflated completely.The device was not prepped outside the anatomy prior to use.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Event Description
Subsequent to the initial report, additional information was received.The deflation time was 20 seconds.No additional information was provided.
 
Manufacturer Narrative
Device codes: 2017 labeled.Internal file number - (b)(4).Correction - reg#.Device code 2017 added: failure to follow steps.The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history did not indicate a lot specific quality issue.It should be noted that the xience xpedition, everolimus eluting coronary stent system (eecss), instructions for use, states: prepare an inflation device / syringe with diluted contrast medium.Attach an inflation device / syringe to the stopcock; attach it to the inflation port.With the tip down, orient the delivery system vertically.Open the stopcock to delivery system; pull negative for 30 seconds; release to neutral for contrast fill.Close the stopcock to the delivery system; purge the inflation device / syringe of all air.Repeat steps until all air is expelled.It is unknown if the ifu deviation contributed to the reported event.Additionally, the ifu states: deflate the balloon by pulling negative on the inflation device for 30 seconds.Confirm complete balloon deflation before attempting to move the delivery system.It is likely the ifu deviation contributed to the reported deflation issue.The investigation determined the reported deflation issue appears to be related to the use error, as it was reported and confirmed during follow up with the account that negative pressure was held for 20 seconds in order to deflate the balloon.In addition, there was no damage noted to the stent delivery system (sds) during the inspection prior to use or during preparation for use which suggests a product quality issue did not contribute to the reported difficulties.Further interaction with the moderately tortuous, heavily calcified, 80% stenosed lesion during advancement, as resistance was noted, likely resulted in the reported physical resistance.Based on the information reviewed, there is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8739471
MDR Text Key149353509
Report Number2024168-2019-05151
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Remedial Action Other
Type of Report Initial,Followup
Report Date 09/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/27/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/22/2022
Device Catalogue Number1070250-48
Device Lot Number9011541
Was Device Available for Evaluation? No
Date Manufacturer Received08/24/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-